01 4Erleada
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 760
2019 Revenue in Millions : 332
Growth (%) : 129
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 1,291
2020 Revenue in Millions : 760
Growth (%) : 70
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,881
2021 Revenue in Millions : 1,291
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 2,387
2022 Revenue in Millions : 1,881
Growth (%) : 27
LOOKING FOR A SUPPLIER?